Fasinex 240, 240 mg/ml Oral Suspension for Cattle

Care should be taken to avoid the following practices because they increase the risk
of development of resistance and could ultimately result in ineffective therapy.
• Too frequent and repeated use of anthelmintics from the same class, over an
extended period
of time.
• Underdosing, which may be due to underestimation of bodyweight,
misadministration of the
veterinary medicinal product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test).
Where the results of the test(s) strongly suggest resistance to a particular
anthelmintic, an anthelmintic belonging to another pharmacological class and having
a different mode of action should be used.
Resistance to triclabendazole has been reported in Fasciola hepatica in a number of
countries including ones in the EU. Therefore, the use of this veterinary medicinal
product should be based on local epidemiological information about susceptibility of
F. hepatica
anthelmintics. Dosing programmes should be discussed with your Veterinary Adviser.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Do not eat, drink, or smoke while handling the veterinary medicinal product. Wash
hands and exposed skin after handling the veterinary medicinal product.
In case of accidental spillage onto skin or in eyes, wash immediately with water. Take
off any contaminated clothes.
Special precautions for the protection of the environment:
Not applicable.
Other precautions
None known.